Inhibition of vasodilator neurotransmission in the sheep middle cerebral artery by VIP antiserum

Journal of Autonomic Pharmacology

Volumn 17, Issue 1, 1997, Pages 13-19

  Matthew, J D ^a,c   Wadsworth, R M ^a   McPhaden, A R ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CYCLIC GMP; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTIBODY;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; IMMUNOREACTIVITY; MIDDLE CEREBRAL ARTERY; NEUROTRANSMISSION; NONHUMAN; SHEEP; VASODILATATION;

EID: 0030956001     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1997.00435.x     Document Type: Article

References (28)

1. AYAJIKI, K., OKAMURA, T. & TODA, N. (1983). Nitric Oxide mediates, and acetylcholine modulates, neurally induced relaxation of bovine cerebral arteries. Neuroscience, 54, 819-825.
2. BRAYDEN, J.E. & BEVAN, J.A. (1986). Evidence that vasoactive intestinal polypeptide (VIP) mediates neurogenic vasodilation of feline cerebral arteries. Stroke, 17, 1189-1192.
3. DUCKLES, S.P. & SAID, S.I. (1982). Vasoactive intestinal peptide as a neurotransmitter in the cerebral circulation. Eur. J. Pharmacol., 78, 371-374.
4. DUCKLES, S.P. (1986). Effects of capsaicin on vascular smooth muscle. Naunyn-Schmiederbergs Arch. Pharmacol., 333, 59-64.
5. EDVINSSON, L. & EKMAN, R. (1984). Distribution and dilatory effect of vasoactive intestinal polypeptide (VIP) in human cerebral arteries. Peptides, 5, 329-331.
6. EDVINSSON, L., FAHRENKRUG, J., HANKO, J., OWMAN, C., SUNDKER, F. & UDDMAN, R. (1980). VIP (Vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals. Cell Tissue Res., 208, 135-142.
7. EDVINSSON, L., HARA, H. & UDDMAN, R. (1989). Retrograde tracing of nerve fibres to the rat middle cerebral artery with true blue: co-localisation with different peptides. J. Cereb. Blood Flow Met., 9, 212-218.
8. EDVINSSON, L., JANSEN, I., KINGMAN, T.A. & MCCULLOCH, J. (1990). Cerebrovascular responses to capsaicin in vitro and in situ. Br. J. Pharmacol., 100, 312-318.
9. ELLIS, J.L. & FARMER, S.G. (1989). The effects of vasoactive intestinal peptide antagonists, and VIP and peptide histidine isoleucine antisera on non-adrenergic non-cholinergic relaxations of tracheal smooth muscle. Br. J. Pharmacol., 96, 513-520.
10. ENOKIBORI, M., OKAMURA, T. & TODA, N. (1994). Mechanism underlying substance P-induced relaxation in dog isolated superficial temporal arteries. Br. J. Pharmacol., 111, 77-82.
11. GARCIA-PASCUAL, A. & TRIGUERO, D. (1994). Relaxation mechanisms induced by stimulation of nerves and by nitric oxide in sheep urethral muscle. J. Physiol., 476, 333-347.
12. G-monomethyl arginine in endothelium-denuded vessels. Br. J. Pharmacol., 102, 567-572.
13. GOADSBY, P.J. & SHELLY, S. (1990). High-frequency stimulation of the facial nerve results in local cortical release of vasoactive intestinal polypeptide in the anaesthetised cat. Neurosci. Lett., 112, 282-289.
14. GRIDER, J.R. & MAHKLOUF, G.M. (1986). Colonic peristaltic reflex: identification of vasoactive intestinal peptide as mediator of descending relaxation. Am. J. Physiol., 251, G40-G45.
15. GRIDER, J.R. & RIVIER, J.R. (1990). Vasoactive intestinal peptide as transmitter of inhibitory neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum. J. Pharmacol. Exp. Ther., 253, 738-742.
16. GRIDER, J.R. (1993). Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis. Am. J. Physiol., 264, G334-G340.
17. HOLZER, P. (1991). Capsaicin: cellular targets, mechanisms of action and selectivity for thin, sensory neurones. Pharmacol. Rev., 43, 143-201.
18. HUIZINGA, J.D., TOMLINSON, J. & PINTIN-QUEZADA, J. (1992). Involvement of nitric oxide in nerve-mediated inhibition and action of vasoactive intestinal peptide in colonic smooth muscle. J. Pharmacol. Exp. Ther., 260, 803-808.
19. JIN, J.G., MURTHY, K.S., GRIDER, J.R. & MAHKLOUF, G.M. (1993). Activation of distinct cAMP- and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells. Am. J. Physiol., 264, G470-G477.
20. LEE, T.J.-F., SAITO, A. & BEREZIN, I. (1984). Vasoactive intestinal polypeptide-like substance: the potential transmitter for cerebral vasodilation. Science, 224, 898-901.
21. LEFEBVRE, R.A., SMITS, G.J.M. & TIMMERMANS, J.P. (1995). Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus. Br. J. Pharmacol., 116, 2017-2026.
22. LI, C.G. & RAND, M.J. (1990). Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur. J. Pharmacol., 191, 303-309.
23. LI, C.G. & RAND, M.J. (1991). Evidence that part of the NANC relaxant reponse of guinea-pig trachea to electrical field stimulation is mediated by nitric oxide. Br. J. Pharmacol., 102, 91-94.
24. MCCULLOCH, J. & EDVINSSON, L. (1980). The effects of vasoactive intestinal polypeptide upon pial arteriolar calibre, cerebral blood flow, cerebral oxygen consumption and the electroencephalogram. Am. J. Physiol., 238, 449-456.
25. MORRIS, J.L. (1993). Co-transmission from autonomic vasodilator neurons supplying the guinea-pig uterine artery. J. Auton. Nerv. Syst., 42, 11-22.
26. RATTAN, S. & CHAKDER, S. (1992). Role of nitric oxide as a mediator of internal anal sphincter relaxation. Am. J. Physiol., 262, G107-G112.
27. SUZUKI, N., HARDEBO, J.E. & OWMAN, C. (1988). Origins and pathways of cerbrovascular vasoactive intestinal polypeptide-positive nerves in the rat. J. Cer. Blood Flow Met., 8, 697-712.
28. TODA, N. (1982). Relaxant responses to transmural stimulation and nicotine of dog and monkey cerebral arteries. Am. J. Physiol., 243, H145-H153.